Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Teal RW"'
Autor:
Ray EM; Department of Medicine, Division of Oncology, University of North Carolina, Chapel Hill, North Carolina, United States of America.; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, United States of America., Teal RW; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, United States of America.; Connected Health Applications and Interventions Core, University of North Carolina, Chapel Hill, North Carolina, United States of America., Carda-Auten J; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, United States of America.; Connected Health Applications and Interventions Core, University of North Carolina, Chapel Hill, North Carolina, United States of America., Coffman E; Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, United States of America., Sanoff HK; Department of Medicine, Division of Oncology, University of North Carolina, Chapel Hill, North Carolina, United States of America.; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, United States of America.
Publikováno v:
PloS one [PLoS One] 2023 Jun 22; Vol. 18 (6), pp. e0287338. Date of Electronic Publication: 2023 Jun 22 (Print Publication: 2023).
Autor:
Dimond EP; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. Graham Cancer Center and Research Institute, Newark, DE dimonde@mail.nih.gov., Zon RT; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. Graham Cancer Center and Research Institute, Newark, DE., Weiner BJ; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. Graham Cancer Center and Research Institute, Newark, DE., St Germain D; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. Graham Cancer Center and Research Institute, Newark, DE., Denicoff AM; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. Graham Cancer Center and Research Institute, Newark, DE., Dempsey K; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. Graham Cancer Center and Research Institute, Newark, DE., Carrigan AC; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. Graham Cancer Center and Research Institute, Newark, DE., Teal RW; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. Graham Cancer Center and Research Institute, Newark, DE., Good MJ; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. Graham Cancer Center and Research Institute, Newark, DE., McCaskill-Stevens W; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. Graham Cancer Center and Research Institute, Newark, DE., Grubbs SS; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. Graham Cancer Center and Research Institute, Newark, DE., Dimond EP; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. Graham Cancer Center and Research Institute, Newark, DE dimonde@mail.nih.gov., Zon RT; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. Graham Cancer Center and Research Institute, Newark, DE., Weiner BJ; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. Graham Cancer Center and Research Institute, Newark, DE., St Germain D; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. Graham Cancer Center and Research Institute, Newark, DE., Denicoff AM; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. Graham Cancer Center and Research Institute, Newark, DE., Dempsey K; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. Graham Cancer Center and Research Institute, Newark, DE., Carrigan AC; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. Graham Cancer Center and Research Institute, Newark, DE., Teal RW; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. Graham Cancer Center and Research Institute, Newark, DE., Good MJ; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. Graham Cancer Center and Research Institute, Newark, DE., McCaskill-Stevens W; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. Graham Cancer Center and Research Institute, Newark, DE., Grubbs SS; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. Graham Cancer Center and Research Institute, Newark, DE.
Publikováno v:
Journal of oncology practice [J Oncol Pract] 2016 Jan; Vol. 12 (1), pp. 63-4, e23-35. Date of Electronic Publication: 2015 Dec 01.
Autor:
Stanislawek, Wlodek L.1 (AUTHOR) Wlodek.Stanislawek@mpi.govt.nz, Tana, Toni1 (AUTHOR), Rawdon, Thomas G.1 (AUTHOR), Cork, Susan C.2 (AUTHOR), Chen, Kylie3 (AUTHOR), Fatoyinbo, Hammed4 (AUTHOR), Cogger, Naomi4 (AUTHOR), Webby, Richard J.5 (AUTHOR), Webster, Robert G.5 (AUTHOR), Joyce, Maree1 (AUTHOR), Tuboltsev, Mary Ann6 (AUTHOR), Orr, Della1 (AUTHOR), Ohneiser, Sylvia1 (AUTHOR), Watts, Jonathan1 (AUTHOR), Riegen, Adrian C.7 (AUTHOR), McDougall, Matthew8 (AUTHOR), Klee, David8 (AUTHOR), O'Keefe, Joseph S.1 (AUTHOR)
Publikováno v:
PLoS ONE. 6/3/2024, Vol. 19 Issue 6, p1-24. 24p.
Publikováno v:
Frontiers in Oncology; 2024, p1-10, 10p
This new edition brings you up-to-date on the role of pharmaceutics and its future paradigms in the design of medicines. Contributions from over 30 international thought leaders cover the core disciplines of pharmaceutics and the impact of biotechnol
Volume 2 addresses the applications and approaches in advanced drug delivery systems, including transdermal, pulmonary, and ocular routes. In addition, this text discusses the impact of the shift to personalized medicines in the fields of pharmaceuti